Sector BioCryst Pharmaceuticals, Inc.

Stocks

BCRX

US09058V1035

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 11:02:12 15/07/2026 pm IST 5-day change 1st Jan Change
9.420 USD -3.29% Intraday chart for BioCryst Pharmaceuticals, Inc. -15.44% +20.45%
Main competitors
Change 5-day change 1-month change 3-month change YTD change 1-year change 3-year change 5-year change 10-year change Capi.($)
-3.29%-15.44%+3.70%-0.48%+20.45%+7.74%+30.67%-40.54%+217.40% 247.55Cr
-1.39%-6.15%-1.39%+5.72%+4.72%+56.05%+71.53%+193.55%+5,501.49% 5.45TCr
+3.13%+11.16%+31.88%+23.42%+45.08%+67.30%+94.35%-18.43% - 5.59TCr
-0.64%-6.38%+11.94%-25.65%-37.31%+6.06%+427.05%+296.87%+857.02% 2.39TCr
+0.30%-3.35%-0.44%-9.12%-5.04%-18.30%-15.68%-59.11% - 2.29TCr
+3.51%+7.50%+27.22%+6.23%+25.76%+47.81%-3.33%-71.72% - 2TCr
+1.94%+0.21%+18.95%+3.10%-6.46%+39.31%-29.41%-30.42%+66.02% 1.75TCr
+10.00%-2.06%+54.29%+128.08%+211.54%+210.10%+370.99%+1,748.60%+671.24% 1.54TCr
+7.69%+4.38%+29.21%+10.57%+36.79%+56.51%+712.88% - - 1.52TCr
-0.39%-0.62%+5.21%+25.93%+27.22%+26.55%+190.57%+220.28%+560.66% 1.4TCr
+1.85%-3.64%+9.02%+5.06%-6.44%+75.11%+144.29%+476.06% - 1.24TCr
-2.62%-4.08%+6.51%-28.74%-13.95%-38.22%+600.00%+114.08%+99.34% 1.2TCr
+7.98%+5.99%+12.50%-24.95%-8.41%-12.44%+178.98%+67.75% - 1.13TCr
+0.66%-3.03%+15.31%+25.91%+29.54%+116.55%+143.45%+326.04%+732.25% 1.11TCr
-1.24%-17.39%-8.19%-0.17%+6.69%+301.76%+104.12%+12.16%+1,119.10% 1.01TCr
+0.02%+0.15%+0.58%+18.03%+23.23%+46.54%+199.13% - - 983.43Cr
+4.24%+5.20%+15.36%-20.66%+19.44%+34.48%+98.39%-21.10% - 925.06Cr
+0.26%+0.51%+138.94%+111.00%+80.27%+163.63%+320.42%+325.75% - 882.64Cr
+2.52%+4.81%+19.63%+44.93%+205.22%+553.10%+566.60%-42.94%-11.51% 870.13Cr
+0.11%-4.50%+13.14%-7.25%+21.52%+58.93%+17.65%+173.65% - 811.66Cr
Average +1.74%-1.85%+20.17%+14.55%+33.99%+89.93%+211.13%+203.92%+981.30% 1.72TCr
Weighted average by Cap. +1.73%-0.62%+18.32%+13.09%+27.83%+72.43%+181.00%+184.33%+2,125.75%
Bio Therapeutic Drugs
  1. Stock Market
  2. Stocks
  3. BCRX Stock
  4. Sector BioCryst Pharmaceuticals, Inc.